Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
Gene | FGFR2 |
Variant | V563L |
Impact List | missense |
Protein Effect | gain of function - predicted |
Gene Variant Descriptions | FGFR2 V563L (corresponds to V562L in the canonical isoform) lies within the protein kinase domain of the Fgfr2 protein (UniProt.org). V563L is predicted to confer a gain of function to the Fgfr2 protein as indicated by increased Fgfr2 kinase activity in cell culture, and has been shown to be associated with secondary resistance to FGFR inhibitors (PMID: 25169980, PMID: 31109923). |
Associated Drug Resistance | Y |
Category Variants Paths |
FGFR2 mutant FGFR2 act mut FGFR2 V563L |
Transcript | NM_001144913.1 |
gDNA | chr10:g.121496711C>G |
cDNA | c.1687G>C |
Protein | p.V563L |
Source Database | RefSeq |
Genome Build | GRCh38/hg38 |
Transcript | gDNA | cDNA | Protein | Source Database | Genome Build |
---|---|---|---|---|---|
NM_022970.3 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_024447888.1 | chr10:g.121488077C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_024447890.1 | chr10:g.121488083C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_017015922 | chr10:g.121488077C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144913 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_024447888.2 | chr10:g.121488077C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_024447890.2 | chr10:g.121488083C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
XM_006717711 | chr10:g.121488083C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144917.2 | chr10:g.121487376C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_022970 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144917 | chr10:g.121487376C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144913.1 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_022970.4 | chr10:g.121496711C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
NM_001144917.1 | chr10:g.121487376C>G | c.1687G>C | p.V563L | RefSeq | GRCh38/hg38 |
Molecular Profile | Indication/Tumor Type | Response Type | Therapy Name | Approval Status | Evidence Type | Efficacy Evidence | References |
---|